Viewing Study NCT01942135


Ignite Creation Date: 2025-12-24 @ 10:42 PM
Ignite Modification Date: 2025-12-31 @ 9:19 PM
Study NCT ID: NCT01942135
Status: COMPLETED
Last Update Posted: 2024-04-04
First Post: 2013-09-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
Sponsor: Pfizer
Organization: